EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Pre‐engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis

Aude Nguyen iD, Jordan Fender, Johan Courjon, Adrien Fischer, Maria Mappoura, Sarah Morin, Federica Giannotti, Anne-Claire Mamez, Yves Chalandon, Stavroula Masouridi-Levrat, Dionysios Neofytos

Transplant Infectious Disease · 2024

DOI: 10.1111/tid.14375 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Aude Nguyen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland. Hauptthemen laut MEDLINE: Bacteremia, Hematopoietic Stem Cell Transplantation, Fluoroquinolones, Transplantation, Homologous. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bacteremia is a common complication in allogeneic hematopoietic cell transplant recipients (alloHCTr), especially during the pre‐engraftment period. International guidelines recommend antibacterial prophylaxis (ABP), despite potential selection for multidrug‐resistant organisms (MDRO). Limited contemporary data exist on the epidemiology of pre‐engraftment bacteremia in alloHCTr, who do not receive ABP.

Methods

We performed a retrospective observational single‐center cohort study including all consecutive adult alloHCTr (2015–2021), investigating the incidence, risk factors, and outcomes of bacteremia during the engraftment period. Primary fluoroquinolone (FQ) ABP is not routinely administered in our center.

Results

Among 421 patients identified, 124 bacteremia episodes were observed in 121/421 (29%) alloHCTr. The median time to the 1st bacteremia episode was 9 days (IQR 6–11). Most (105/124, 85%) episodes were monomicrobial, while >1 pathogens were identified in 19/124 (15%) episodes. Overall, 152 pathogens were isolated, with a predominance of Gram‐positive (118/152, 78%), including coagulase‐negative staphylococci ( n :47), streptococci ( n :46), and enterococci ( n :15), followed by Gram‐negative bacteria (GNB, 30/152, 20%), and anaerobes (4/152, 3%). There were 2/152 (1%) MDRO (extended‐spectrum beta‐lactamase producing) GNB. Multivariable analyses identified age >40‐year‐old (OR 2.4, P = 0.02), male gender (OR 1.8, P = 0.02), and a haploidentical/mismatched unrelated donor (OR 2.5, P < 0.001) as independent risk factors for bacteremia. All cause 30‐day mortality among alloHCTr with bacteremia was 0.8% (1/121): one patient died due to an HCT‐related complication.

Conclusion

Despite lack of primary FQ ABP, low rates of bacteremia were observed during the pre‐engraftment period, with low MDRO prevalence and mortality. Our findings may allow to revisit the need for primary universal FQ ABP in high‐risk neutropenic hematology patients. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BacteremiaHematopoietic Stem Cell TransplantationFluoroquinolonesTransplantation, HomologousAnti-Bacterial AgentsAntibiotic ProphylaxisHumansMaleFemaleRetrospective StudiesMiddle AgedAdultRisk FactorsAgedIncidence

Stichwörter der Autor:innen

allogeneic hematopoietic stem cell transplantationantibacterial prophylaxisantibioticsbacteremiabloodstream infectionengraftment period

Substanzen

FluoroquinolonesAnti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
  • Infection Control Program and WHO Collaborating Centre, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
  • Department of Internal Medicine, Rehabilitation and Geriatrics, Internal Medicine and Rehabilitation Unit, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
  • Infectious Diseases Unit, University Côte d'Azur, CHU Nice, Nice, France.
  • Bacteriology Laboratory, Department of Diagnostics, Geneva University Hospitals, Geneva, Switzerland.
  • Hematology Division, Department of Oncology, University Hospital of Geneva, and Faculty of Medicine, Geneva, Switzerland.

ORCID-Profile: Aude Nguyen

Zitieren

APA

Nguyen, A., Fender, J., Courjon, J., Fischer, A., Mappoura, M., Morin, S., Giannotti, F., Mamez, A. C., Chalandon, Y., Masouridi-Levrat, S., & Neofytos, D. (2024). Pre‐engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis. Transplant Infectious Disease. https://doi.org/10.1111/tid.14375

Vancouver

Nguyen A, Fender J, Courjon J, Fischer A, Mappoura M, Morin S, et al. Pre‐engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis. Transplant Infectious Disease. 2024. doi:10.1111/tid.14375

BibTeX
@article{Nguyen2024,
  author = {Nguyen, Aude and Fender, Jordan and Courjon, Johan and Fischer, Adrien and Mappoura, Maria and Morin, Sarah and Giannotti, Federica and Mamez, Anne-Claire and Chalandon, Yves and Masouridi-Levrat, Stavroula and Neofytos, Dionysios},
  title = {Pre‐engraftment bacteremia after allogeneic hematopoietic cell transplantation without primary fluoroquinolone antibacterial prophylaxis},
  journal = {Transplant Infectious Disease},
  year = {2024},
  doi = {10.1111/tid.14375}
}
Kostenlos starten →